{
    "filename": "s41591-020-0775-x.pdf",
    "content_type": "application/pdf",
    "file_size": 331699,
    "metadata": {
        "identifiers": {
            "doi": "10.1038/s41591-020-0775-x",
            "arxiv": null,
            "isbn": null,
            "doc_id": null,
            "url": "https://www.nature.com/articles/s41591-020-0775-x.pdf"
        },
        "title": "Communication, collaboration and cooperation can stop the 2019 coronavirus",
        "date": 2020,
        "affiliations": [
            "Vaccine Research Center of the US National Institutes of Health communicated the 2019-nCoV viral sequence to collaborators at Moderna, which has initiated goodmanufacturing-practice production of an",
            "RNA platform, to help accelerate clinical testing of a vaccine against 2019-nCoV."
        ],
        "journal": "Nature Medicine",
        "volume": "26",
        "abstract": "As the outbreak of a deadly new coronavirus in China and its rapid spread is rattling countries, only the collective international experience and advances derived from past outbreaks can accelerate its control.",
        "links": [
            "http://virological.org/t/",
            "http://www.nature.com/naturemedicine",
            "https://www.thelancet"
        ],
        "pages": "151-151",
        "references": "",
        "references_ris": "",
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": []
    },
    "sections": {
        "introduction": [
            "As the outbreak of a deadly new coronavirus in China and its rapid spread is rattling countries, only the collective international experience and advances derived from past outbreaks can accelerate its control.",
            "On 31 December 2019, the World Health Organization was alerted about a cluster of pneumonia cases of unknown etiology in Wuhan, China, which prompted international concern of the potential public-health impact of an outbreak of a new virus. Those initial concerns have proven justified: at the time of this writing, it has been confirmed that thousands of people have been infected, and of those, almost 3% have died. With the now global spread of the virus, the urgency of a coordinated international response has amplified."
        ]
    },
    "structured_content": {},
    "participants": [
        {
            "participant": "people",
            "number": 774,
            "context": "Experience gained from viral outbreaks over the past two decades has also better positioned the international response in terms of scope and speed. <mark class=\"stats\">The SARS outbreak, which killed 774 people worldwide, and the 2012 emergence of the related coronavirus Middle East respiratory syndrome coronavirus (MERS-CoV) stimulated the development of a broad array of research tools, vaccine platforms, diagnostics and potential therapeutics that have yielded extensive scientific insights into coronavirus biology and are now being translated to the new virus</mark>. That progress, coupled with lessons learned from the outbreaks of Zika, Ebola and Chikungunya viruses, should enable rapid containment of 2019-nCoV"
        }
    ],
    "statistics": [],
    "keywords": [
        "severe acute respiratory syndrome",
        "world health organization",
        "coronavirus",
        "pneumonia case",
        "initial concern",
        "past outbreak",
        "rapid spread",
        "unknown etiology",
        "new virus",
        "coordinated international response",
        "international concern",
        "potential public health impact",
        "collective international experience",
        "deadly new coronavirus",
        "global spread"
    ],
    "keyword_relevance": {
        "coronavirus": 0.3548387096774194,
        "severe acute respiratory syndrome": 0.25806451612903225,
        "new virus": 0.06451612903225806,
        "pneumonia case": 0.03225806451612903,
        "initial concern": 0.03225806451612903,
        "past outbreak": 0.03225806451612903,
        "rapid spread": 0.03225806451612903,
        "unknown etiology": 0.03225806451612903,
        "coordinated international response": 0.03225806451612903,
        "international concern": 0.03225806451612903,
        "collective international experience": 0.03225806451612903,
        "deadly new coronavirus": 0.03225806451612903,
        "global spread": 0.03225806451612903,
        "world health organization": 0.0,
        "potential public health impact": 0.0
    },
    "species": [],
    "summary": [
        "As the outbreak of a deadly new coronavirus in China and its rapid spread is rattling countries, only the collective international experience and advances derived from past outbreaks can accelerate its control.",
        "On 31 December 2019, the World Health Organization was alerted about a cluster of pneumonia cases of unknown etiology in Wuhan, China, which prompted international concern of the potential public-health impact of an outbreak of a new virus.",
        "The public release of the 2019-nCoV viral sequence was needed to empower the global community to collectively mobilize research efforts to help in the containment of this virus.",
        "The SARS outbreak, which killed 774 people worldwide, and the 2012 emergence of the related coronavirus Middle East respiratory syndrome coronavirus (MERS-CoV) stimulated the development of a broad array of research tools, vaccine platforms, diagnostics and potential therapeutics that have yielded extensive scientific insights into coronavirus biology and are being translated to the new virus.",
        "On 13 January 2020, the Vaccine Research Center of the US National Institutes of Health communicated the 2019-nCoV viral sequence to collaborators at Moderna, which has initiated goodmanufacturing-practice production of an mRNA vaccine targeting the viral spike glycoprotein.",
        "Investigators in China report that a clinical trial of the antivirals lopinavir and ritonavir, used to treat some patients with SARS and MERS, has been initiated in hospitalized patients infected with 2019-nCoV (https://www.thelancet.",
        "This multi-pronged approach to curtail the outbreak, strongly supported by existing R&D, is a testament to the collaborative response of international organizations and the research and clinical communities.",
        "At the time of this writing, only China had access to the intact virus, which means that other countries would need to create it anew by reverse engineering or by isolating the virus from infected people.",
        "Virus-surveillance efforts did not detect 2019-nCoV, and initially local authorities did not broadly acknowledge its possible health impact, despite existing knowledge of related viruses.",
        "This speaks dually to the need for continued surveillance and emergency planning, and to the importance of publicizing health outbreaks as they occur to optimize response coordination and to engage the lay community in active risk prevention, even at early stages.",
        "In the face of global infectious-disease emergencies, countries have a responsibility to be transparent in their reporting and actions, both to their own populations and to the international community, in order to facilitate and accelerate cooperation that will curtail outbreaks and minimize harm."
    ],
    "structured_summary": {
        "Introduction": [
            "As the outbreak of a deadly new coronavirus in China and its rapid spread is rattling countries, only the collective international experience and advances derived from past outbreaks can accelerate its control.",
            "On 31 December 2019, the World Health Organization was alerted about a cluster of pneumonia cases of unknown etiology in Wuhan, China, which prompted international concern of the potential public-health impact of an outbreak of a new virus."
        ],
        "Results": [
            "The public release of the 2019-nCoV viral sequence was needed to empower the global community to collectively mobilize research efforts to help in the containment of this virus.",
            "The SARS outbreak, which killed 774 people worldwide, and the 2012 emergence of the related coronavirus Middle East respiratory syndrome coronavirus (MERS-CoV) stimulated the development of a broad array of research tools, vaccine platforms, diagnostics and potential therapeutics that have yielded extensive scientific insights into coronavirus biology and are being translated to the new virus.",
            "On 13 January 2020, the Vaccine Research Center of the US National Institutes of Health communicated the 2019-nCoV viral sequence to collaborators at Moderna, which has initiated goodmanufacturing-practice production of an mRNA vaccine targeting the viral spike glycoprotein.",
            "Investigators in China report that a clinical trial of the antivirals lopinavir and ritonavir, used to treat some patients with SARS and MERS, has been initiated in hospitalized patients infected with 2019-nCoV (https://www.thelancet.",
            "This multi-pronged approach to curtail the outbreak, strongly supported by existing R&D, is a testament to the collaborative response of international organizations and the research and clinical communities.",
            "At the time of this writing, only China had access to the intact virus, which means that other countries would need to create it anew by reverse engineering or by isolating the virus from infected people.",
            "Virus-surveillance efforts did not detect 2019-nCoV, and initially local authorities did not broadly acknowledge its possible health impact, despite existing knowledge of related viruses."
        ],
        "Conclusion": [
            "This speaks dually to the need for continued surveillance and emergency planning, and to the importance of publicizing health outbreaks as they occur to optimize response coordination and to engage the lay community in active risk prevention, even at early stages.",
            "In the face of global infectious-disease emergencies, countries have a responsibility to be transparent in their reporting and actions, both to their own populations and to the international community, in order to facilitate and accelerate cooperation that will curtail outbreaks and minimize harm."
        ]
    },
    "reference_links": [],
    "facts": [
        "the collective international experience and advances derived from past outbreaks can accelerate its control",
        "the World Health Organization was alerted about a cluster of pneumonia cases",
        "the global community to collectively mobilize research efforts to help in the containment of this virus",
        "the 2012 emergence of the related coronavirus Middle East respiratory syndrome coronavirus stimulated the development of a broad array of research tools",
        "Investigators in China report that a clinical trial of the antivirals lopinavir and ritonavir",
        "which means that other countries would need to create",
        "a responsibility to be transparent in their reporting and actions"
    ],
    "claims": [],
    "findings": [],
    "processes": [],
    "key_statements": [
        "As the outbreak of a deadly new coronavirus in China and its rapid spread is rattling countries, only the collective international experience and advances derived from past outbreaks can accelerate its control",
        "On 31 December 2019, the World Health Organization was alerted about a cluster of pneumonia cases of unknown etiology in Wuhan, China, which prompted international concern of the potential public-health impact of an outbreak of a new virus",
        "The public release of the 2019-nCoV viral sequence was needed to empower the global community to collectively mobilize research efforts to help in the containment of this virus",
        "In the face of global infectious-disease emergencies, countries have a responsibility to be transparent in their reporting and actions, both to their own populations and to the international community, in order to facilitate and accelerate cooperation that will curtail outbreaks and minimize harm"
    ],
    "top_statements": [
        "As the outbreak of a deadly new coronavirus in China and its rapid spread is rattling countries, only the collective international experience and advances derived from past outbreaks can accelerate its control",
        "On 31 December 2019, the World Health Organization was alerted about a cluster of pneumonia cases of unknown etiology in Wuhan, China, which prompted international concern of the potential public-health impact of an outbreak of a new virus",
        "The public release of the 2019-nCoV viral sequence was needed to empower the global community to collectively mobilize research efforts to help in the containment of this virus",
        "In the face of global infectious-disease emergencies, countries have a responsibility to be transparent in their reporting and actions, both to their own populations and to the international community, in order to facilitate and accelerate cooperation that will curtail outbreaks and minimize harm"
    ],
    "headline": "As the outbreak of a deadly new coronavirus in China and its rapid spread is rattling countries, only the collective international experience and advances derived from past outbreaks can accelerate its control",
    "contexts": [],
    "abbreviations": {
        "SARS": "severe acute respiratory syndrome"
    }
}
